Le Lézard
Classified in: Health
Subject: CCA

Invitation to Essity's Year-end Report 2019 Press Conference


STOCKHOLM, Dec. 18, 2019 /PRNewswire/ --  The press conference held in connection with the publication of Essity's Year-end Report for 2019 will also be available via webcast and it is possible to join by phone.

The Year-end Report will be published on January 22, 2020 at approximately 07:00 CET. The subsequent press conference will be held at 09:00 CET at Essity's headquarters, Waterfront Building, Klarabergsviadukten 63, Stockholm, Sweden.

At the press conference, President and CEO Magnus Groth will present and answer questions regarding the report.

Press conference: 

Date: Wednesday, January 22, 2020

Time: 09:00 CET

Venue: Essity Headquarters, Waterfront Building, Klarabergsviadukten 63, Stockholm, Sweden

Link to webcast:

https://essity.videosync.fi/2020-01-22-q4

The press conference will be webcast live at www.essity.com . It is also possible to participate in the press conference by telephone by calling +44 (0) 207-192-80-00, +1-631-510-74-95 or +46(0)8-506-921-80. Call in good time before the conference starts. Provide the code "Essity" or the conference ID 3561699.

CONTACT:

For further information, please contact:

Per Lorentz, Vice President Corporate Communications, +46-8-788-52-51, [email protected]

Johan Karlsson, Vice President Investor Relations, +46-8-788-51-30, [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/essity/r/invitation-to-essity-s-year-end-report-2019-press-conference,c2991974

The following files are available for download:

https://mb.cision.com/Main/15798/2991974/1162533.pdf

Invitation to Essity's Year-end Report 2019 press conference

SOURCE Essity


These press releases may also interest you

at 07:30
KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the...

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....

at 07:10
908 Devices Inc. , a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will...

at 07:10
Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip...

at 07:10
ZYUS Life Sciences Corporation (the "Company") , a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announced today that the USPTO...

at 07:10
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of...



News published on and distributed by: